Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01195077 · ClinicalTrials.gov registry record · Phase 1
Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?
A Phase 1 study, sponsored by University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01195077 is a Phase 1 study that has completed, run by University of South Carolina. The registered enrollment target is 12 participants.
The verdict
NCT01195077, a Phase 1 study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Drawing inferences from epidemiologic studies of HIV/AIDS as well well as cell culture and animal studies of HIV inhibition by algae, we propose algal consumption as one unifying characteristic of countries with anomalously low rates. HIV/AIDS incidence and prevalence in Eastern Asia (\<1/10,000 adults in Japan and Korea), compared to Africa (≈1/10 adults) strongly suggest that differences in IV drug use and sexual behavior are insufficient to explain the 1000-fold variation. Even in Africa, AIDS/HIV rates vary. Spirulina is part of the daily diet for many people living in Chad, where prevalence of HIV has remained at less than 4% for more than 20 years. Average daily algae consumption in Asia and Africa ranges between 1 to 2 tablespoons (3 - 13 grams). HIV viral load is the main indicator of infection, however CD4 helper cell counts are most predictive of morbidity and mortality.We hypothesized that the consumption of algae could be important in diminishing the risk of HIV infection, and subsequent progression, possibly by enhancing the immune response.
Interventions
- OTHER seaweed, spirulina, seaweed + spirulina
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2003-02 |
| Est. Completion | 2008-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01195077
The ClinicalTrials.gov registry entry for NCT01195077 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which seaweed, spirulina, seaweed + spirulina is the first listed.
NCT01195077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01195077 about?
NCT01195077 is a clinical study titled "Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?". Drawing inferences from epidemiologic studies of HIV/AIDS as well well as cell culture and animal studies of HIV inhibition by algae, we propose algal consumption as one unifying characteristic of countries with anomalously low rates. HIV/AIDS incidence and prevalence in Eastern Asia (\<1/10,000 adu...
What is the current status of trial NCT01195077?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2003-02. Estimated completion is 2008-06.
What interventions are being tested in trial NCT01195077?
The interventions under investigation include: seaweed, spirulina, seaweed + spirulina (OTHER).
Who is sponsoring clinical trial NCT01195077?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.